Hangzhou AGS Medtech CoSHSE:688581 -1.78%87 Current Ratio is 17.48 as of Mar. 2026, which is 29% above its 10-year median of 13.57. GuruFocus rates SHSE:688581 with a GF Score™ of 87/100 and a GF Value™ of ¥74.70 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Hangzhou AGS Medtech Co ranks better than 97.89% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Hangzhou AGS Medtech Co's current ratio for the quarter that ended in Mar. 2026 was 17.48.
Hangzhou AGS Medtech Co has a current ratio of 17.48. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Hangzhou AGS Medtech Co's Current Ratio or its related term are showing as below:
SHSE:688581'
s Current Ratio Range Over the Past 10 Years
Min: 1.5 Med: 13.57 Max: 25.06
Current: 17.48
During the past 9 years, Hangzhou AGS Medtech Co's highest Current Ratio was 25.06. The lowest was 1.50. And the median was 13.57.
SHSE:688581's Current Ratio is ranked better than 97.89% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 2.49
vs SHSE:688581: 17.48
Hangzhou AGS Medtech Co (SHSE:688581) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Hangzhou AGS Medtech Co Current Ratio Related Terms
Hangzhou AGS Medtech Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688581 vs ABT, SYK, MDT: Current Ratio Comparison
For the Medical Devices subindustry, Hangzhou AGS Medtech Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou AGS Medtech Co Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou AGS Medtech Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where Hangzhou AGS Medtech Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou AGS Medtech Co (SHSE:688581) has a Current Ratio of 17.48 as of Mar. 2026. This is 29% above median its historical median of 13.57. Over the past decade, Hangzhou AGS Medtech Co's Current Ratio has ranged from 1.50 to 25.06. According to the industry distribution chart, Hangzhou AGS Medtech Co ranks #18 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 2.1%.
Is Hangzhou AGS Medtech Co's Current Ratio too high?
Hangzhou AGS Medtech Co's current Current Ratio of 17.48 is 29% above median its 10-year median of 13.57. Over the past 10 years, this metric has ranged from a low of 1.50 to a high of 25.06. The Medical Devices & Instruments industry median Current Ratio is 2.49. Hangzhou AGS Medtech Co's value of 17.48 is 602% above this industry median. Based on the distribution chart, Hangzhou AGS Medtech Co ranks #18 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Hangzhou AGS Medtech Co has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou AGS Medtech Co's Current Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Hangzhou AGS Medtech Co ranks #18 out of 853 companies for Current Ratio. This places Hangzhou AGS Medtech Co in the top 2% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.49. Hangzhou AGS Medtech Co's value of 17.48 is 602% above this benchmark. Historically, Hangzhou AGS Medtech Co's own Current Ratio has ranged from 1.50 to 25.06 over the past decade. While the company's 10-year median is 13.57 vs. the industry median of 2.49, Hangzhou AGS Medtech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hangzhou AGS Medtech Co's current Current Ratio of 17.48 is 602% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hangzhou AGS Medtech Co's current Current Ratio is 17.48, which is 29% above median its own 10-year median of 13.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou AGS Medtech Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou AGS Medtech Co (SHSE:688581) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥74.70, compared to a current price of ¥52.00 — trading 30.4% below its estimated fair value. The current Current Ratio is 17.48, which is 29% above median its 10-year median of 13.57 and 602% above the Medical Devices & Instruments industry median of 2.49. Hangzhou AGS Medtech Co's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Hangzhou AGS Medtech Co (SHSE:688581), the current Current Ratio is 17.48 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hangzhou AGS Medtech Co (SHSE:688581) Overvalued in 2026?
Based on GuruFocus' analysis, Hangzhou AGS Medtech Co stock appears to be undervalued.
The current stock price of ¥52.00 is trading 30.4% below its estimated GF Value™ of ¥74.70.
GuruFocus considers Hangzhou AGS Medtech Co to be Significantly Undervalued.
Key valuation signals for SHSE:688581:
Current Ratio: 17.48 (29% above median its 10-year median of 13.57)
GF Value™: ¥74.70 vs. price of ¥52.00 (30.4% below fair value)
Industry Position: 602% above the Medical Devices & Instruments median (#18 of 853)
No single metric tells the full story. See the SHSE:688581 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and provide patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.
87GF Score
Get the complete analysis for SHSE:688581
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688581 has been successfully added to your 
